ID   5NT3A_MOUSE             Reviewed;         331 AA.
AC   Q9D020; Q8CI05; Q9D0D9;
DT   13-SEP-2005, integrated into UniProtKB/Swiss-Prot.
DT   14-NOV-2006, sequence version 4.
DT   22-JUL-2015, entry version 115.
DE   RecName: Full=Cytosolic 5'-nucleotidase 3A;
DE            EC=3.1.3.5;
DE   AltName: Full=Cytosolic 5'-nucleotidase 3;
DE   AltName: Full=Cytosolic 5'-nucleotidase III;
DE            Short=cN-III;
DE   AltName: Full=Lupin;
DE   AltName: Full=Pyrimidine 5'-nucleotidase 1;
DE            Short=P5'N-1;
DE            Short=P5N-1;
DE            Short=PN-I;
GN   Name=Nt5c3a; Synonyms=Nt5c3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=11180800; DOI=10.1007/s004270000093;
RA   Lu M.M., Chen F., Gitler A., Li J., Jin F., Ma X.K., Epstein J.A.;
RT   "Cloning and expression analysis of murine lupin, a member of a novel
RT   gene family that is conserved through evolution and associated with
RT   Lupus inclusions.";
RL   Dev. Genes Evol. 210:512-517(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   STRAIN=C57BL/6J; TISSUE=Embryo;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=Czech II; TISSUE=Mammary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 118-123, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=OF1; TISSUE=Hippocampus;
RA   Lubec G., Sunyer B., Chen W.-Q.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [5]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) (ISOFORM 1) IN COMPLEXES WITH
RP   MAGNESIUM; PHOSPHATE; TRANSITION STATE ANALOG AND LEAD IONS.
RX   PubMed=16672222; DOI=10.1074/jbc.M602000200;
RA   Bitto E., Bingman C.A., Wesenberg G.E., McCoy J.G., Phillips G.N. Jr.;
RT   "Structure of pyrimidine 5'-nucleotidase type 1. Insight into
RT   mechanism of action and inhibition during lead poisoning.";
RL   J. Biol. Chem. 281:20521-20529(2006).
CC   -!- FUNCTION: Can act both as nucleotidase and as phosphotransferase.
CC       {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY: A 5'-ribonucleotide + H(2)O = a ribonucleoside
CC       + phosphate.
CC   -!- SUBUNIT: Monomer.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=2;
CC         IsoId=Q9D020-3; Sequence=Displayed;
CC       Name=1;
CC         IsoId=Q9D020-1; Sequence=VSP_021566;
CC   -!- TISSUE SPECIFICITY: Isoform 2 is highly expressed in the brain,
CC       heart, spleen, kidney and blood. Isoform 2 is expressed (at
CC       protein level) in the spleen, skeletal muscle and gastrointestinal
CC       epithelia.
CC   -!- DEVELOPMENTAL STAGE: Isoform 2 is weakly expressed from E7.5 and
CC       the expression level steadily increases through gestation. At E9.5
CC       and E10.5 is first detected colocalizing with embryonic blood
CC       cells within the region of the septum transversum and within the
CC       cardiac chambers and dorsal aorta. At E12.5 expression is found in
CC       the ventral neural tube and in the trigeminal ganglia and in the
CC       liver and dorsal root ganglia. Expression persists in the liver,
CC       dorsal root and trigeminal ganglia at E13.5 and weaker expression
CC       becomes apparent in cardiac and skeletal muscle. At E16.5
CC       expression is detected in liver, myocardium, tongue, bronchial
CC       epithelium, gastrointestinal epithelium, cartilage and forebrain
CC       neuroepithelium.
CC   -!- SIMILARITY: Belongs to the pyrimidine 5'-nucleotidase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK011525; BAB27677.2; -; mRNA.
DR   EMBL; AK011894; BAB27901.2; -; mRNA.
DR   EMBL; BC038029; AAH38029.1; -; mRNA.
DR   CCDS; CCDS20171.1; -. [Q9D020-3]
DR   CCDS; CCDS57424.1; -. [Q9D020-1]
DR   RefSeq; NP_001239303.1; NM_001252374.1. [Q9D020-1]
DR   RefSeq; NP_080280.3; NM_026004.3. [Q9D020-3]
DR   RefSeq; XP_006505335.1; XM_006505272.1. [Q9D020-1]
DR   RefSeq; XP_006505336.1; XM_006505273.1. [Q9D020-1]
DR   RefSeq; XP_011239413.1; XM_011241111.1. [Q9D020-1]
DR   UniGene; Mm.158936; -.
DR   PDB; 2BDU; X-ray; 2.35 A; A/B=46-331.
DR   PDB; 2G06; X-ray; 2.25 A; A/B=46-331.
DR   PDB; 2G07; X-ray; 2.30 A; A/B=46-331.
DR   PDB; 2G08; X-ray; 2.35 A; A/B=46-331.
DR   PDB; 2G09; X-ray; 2.10 A; A/B=46-331.
DR   PDB; 2G0A; X-ray; 2.35 A; A/B=46-331.
DR   PDB; 2Q4T; X-ray; 2.35 A; A/B=46-331.
DR   PDB; 4FE3; X-ray; 1.74 A; A=46-331.
DR   PDB; 4KX3; X-ray; 2.10 A; A=46-331.
DR   PDB; 4KX5; X-ray; 1.90 A; A=46-331.
DR   PDBsum; 2BDU; -.
DR   PDBsum; 2G06; -.
DR   PDBsum; 2G07; -.
DR   PDBsum; 2G08; -.
DR   PDBsum; 2G09; -.
DR   PDBsum; 2G0A; -.
DR   PDBsum; 2Q4T; -.
DR   PDBsum; 4FE3; -.
DR   PDBsum; 4KX3; -.
DR   PDBsum; 4KX5; -.
DR   ProteinModelPortal; Q9D020; -.
DR   SMR; Q9D020; 44-331.
DR   IntAct; Q9D020; 1.
DR   MINT; MINT-4126326; -.
DR   STRING; 10090.ENSMUSP00000031793; -.
DR   PhosphoSite; Q9D020; -.
DR   MaxQB; Q9D020; -.
DR   PaxDb; Q9D020; -.
DR   PRIDE; Q9D020; -.
DR   DNASU; 107569; -.
DR   Ensembl; ENSMUST00000031793; ENSMUSP00000031793; ENSMUSG00000029780. [Q9D020-3]
DR   Ensembl; ENSMUST00000101367; ENSMUSP00000098918; ENSMUSG00000029780. [Q9D020-1]
DR   GeneID; 107569; -.
DR   KEGG; mmu:107569; -.
DR   UCSC; uc009cbq.3; mouse. [Q9D020-1]
DR   UCSC; uc009cbr.3; mouse. [Q9D020-3]
DR   CTD; 107569; -.
DR   MGI; MGI:1927186; Nt5c3.
DR   eggNOG; NOG266578; -.
DR   GeneTree; ENSGT00390000012959; -.
DR   HOGENOM; HOG000244931; -.
DR   HOVERGEN; HBG059750; -.
DR   InParanoid; Q9D020; -.
DR   KO; K01081; -.
DR   OMA; AGVYHSN; -.
DR   OrthoDB; EOG7XSTHV; -.
DR   PhylomeDB; Q9D020; -.
DR   TreeFam; TF314663; -.
DR   Reactome; REACT_317918; Pyrimidine catabolism.
DR   EvolutionaryTrace; Q9D020; -.
DR   NextBio; 359058; -.
DR   PRO; PR:Q9D020; -.
DR   Proteomes; UP000000589; Chromosome 6.
DR   Bgee; Q9D020; -.
DR   CleanEx; MM_NT5C3; -.
DR   ExpressionAtlas; Q9D020; baseline and differential.
DR   Genevisible; Q9D020; MM.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:MGI.
DR   GO; GO:0008253; F:5'-nucleotidase activity; ISS:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0016740; F:transferase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016311; P:dephosphorylation; ISO:MGI.
DR   GO; GO:0009117; P:nucleotide metabolic process; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.50.1000; -; 2.
DR   InterPro; IPR023214; HAD-like_dom.
DR   InterPro; IPR006383; HAD-SF_hydro_IB_PSP-like.
DR   InterPro; IPR006434; Pyrimidine_nucleotidase_eu.
DR   PANTHER; PTHR13045; PTHR13045; 1.
DR   Pfam; PF05822; UMPH-1; 1.
DR   SUPFAM; SSF56784; SSF56784; 1.
DR   TIGRFAMs; TIGR01488; HAD-SF-IB; 1.
DR   TIGRFAMs; TIGR01544; HAD-SF-IE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; Cytoplasm;
KW   Direct protein sequencing; Hydrolase; Magnesium; Metal-binding;
KW   Nucleotide metabolism; Nucleotide-binding; Reference proteome;
KW   Transferase.
FT   CHAIN         1    331       Cytosolic 5'-nucleotidase 3A.
FT                                /FTId=PRO_0000064388.
FT   REGION      198    200       Substrate binding.
FT   ACT_SITE     83     83       Nucleophile.
FT   ACT_SITE     85     85       Proton donor.
FT   METAL        83     83       Magnesium.
FT   METAL        85     85       Magnesium; via carbonyl oxygen.
FT   METAL       272    272       Magnesium.
FT   BINDING     247    247       Substrate.
FT   VAR_SEQ       1     45       MDRAAVARVGAVASASVCAVVAGVVLAQYIFTLKRKTGRKT
FT                                KIIE -> MTNQESAVHLK (in isoform 1).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_021566.
FT   CONFLICT    183    183       F -> L (in Ref. 2; BAB27677).
FT                                {ECO:0000305}.
FT   CONFLICT    260    260       Q -> R (in Ref. 2; BAB27901).
FT                                {ECO:0000305}.
FT   HELIX        48     50       {ECO:0000244|PDB:4FE3}.
FT   STRAND       55     58       {ECO:0000244|PDB:2Q4T}.
FT   HELIX        60     77       {ECO:0000244|PDB:4FE3}.
FT   STRAND       78     82       {ECO:0000244|PDB:4FE3}.
FT   TURN         85     87       {ECO:0000244|PDB:4FE3}.
FT   STRAND       91     93       {ECO:0000244|PDB:4FE3}.
FT   HELIX       101    106       {ECO:0000244|PDB:4FE3}.
FT   HELIX       113    131       {ECO:0000244|PDB:4FE3}.
FT   STRAND      133    135       {ECO:0000244|PDB:4FE3}.
FT   HELIX       137    157       {ECO:0000244|PDB:4FE3}.
FT   HELIX       162    164       {ECO:0000244|PDB:4FE3}.
FT   HELIX       165    170       {ECO:0000244|PDB:4FE3}.
FT   HELIX       180    189       {ECO:0000244|PDB:4FE3}.
FT   STRAND      194    201       {ECO:0000244|PDB:4FE3}.
FT   HELIX       202    211       {ECO:0000244|PDB:4FE3}.
FT   STRAND      219    224       {ECO:0000244|PDB:4FE3}.
FT   STRAND      226    228       {ECO:0000244|PDB:4FE3}.
FT   STRAND      232    237       {ECO:0000244|PDB:4FE3}.
FT   HELIX       247    252       {ECO:0000244|PDB:4FE3}.
FT   HELIX       255    260       {ECO:0000244|PDB:4FE3}.
FT   TURN        261    263       {ECO:0000244|PDB:4FE3}.
FT   STRAND      266    273       {ECO:0000244|PDB:4FE3}.
FT   HELIX       274    278       {ECO:0000244|PDB:4FE3}.
FT   TURN        279    282       {ECO:0000244|PDB:4FE3}.
FT   STRAND      287    295       {ECO:0000244|PDB:4FE3}.
FT   HELIX       299    309       {ECO:0000244|PDB:4FE3}.
FT   STRAND      310    316       {ECO:0000244|PDB:4FE3}.
FT   HELIX       321    330       {ECO:0000244|PDB:4FE3}.
SQ   SEQUENCE   331 AA;  37252 MW;  9BE4CA16863E1E0F CRC64;
     MDRAAVARVG AVASASVCAV VAGVVLAQYI FTLKRKTGRK TKIIEMMPEF QKSSVRIKNP
     TRVEEIICGL IKGGAAKLQI ITDFDMTLSR FSYNGKRCPT CHNIIDNCKL VTDECRRKLL
     QLKEQYYAIE VDPVLTVEEK FPYMVEWYTK SHGLLIEQGI PKAKLKEIVA DSDVMLKEGY
     ENFFGKLQQH GIPVFIFSAG IGDVLEEVIR QAGVYHSNVK VVSNFMDFDE NGVLKGFKGE
     LIHVFNKHDG ALKNTDYFSQ LKDNSNIILL GDSQGDLRMA DGVANVEHIL KIGYLNDRVD
     ELLEKYMDSY DIVLVKEESL EVVNSILQKT L
//
